Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)

References

• SteinerGAtherosclerosis, the major complication of diabetesAdv Exp Med Biol19851892772974036715
   PubMed Web of Science ®Google Scholar
• RossRAtherosclerosis: an inflammatory diseaseN Engl J Med199934021151269887164
   PubMed Web of Science ®Google Scholar
• YokokawaHYasumuraSTannoKSerum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural populationJ Atheroscler Thromb2011182899820972352
   PubMed Web of Science ®Google Scholar
• ItoHOuchiYOhashiYA comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE)J Atheroscler Thromb200182334411770708
   PubMedGoogle Scholar
• SaitoIIsoHKokuboYInoueMTsuganeSMetabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) StudyCirc J200973587888419282609
   PubMed Web of Science ®Google Scholar
• SchwartzSMDebloisDO’BrienERThe intima. Soil for atherosclerosis and restenosisCirc Res19957734454657641318
   PubMed Web of Science ®Google Scholar
• SteinerMReinhardtKMKrammerBErnstBBlannADIncreased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic controlThromb Haemost19947269799847537916
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSNishikawaMFukuharaSSignificance of chemokines and activated platelets in patients with diabetesClin Exp Immunol2000121343744310971508
   PubMed Web of Science ®Google Scholar
• BastardJPJardelCDelattreJHainqueBBruckertEOberlinFEvidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjectsCirculation199999162221222210217702
   PubMed Web of Science ®Google Scholar
• FestaAWilliamsKTracyRPWagenknechtLEHaffnerSMProgression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetesCirculation2006113141753175916585388
   PubMed Web of Science ®Google Scholar
• IshikawaSKayabaKGotohTNakamuraYKajiiEMetabolic syndrome and C-reactive protein in the general population: JMS Cohort StudyCirc J2007711263117186974
   PubMed Web of Science ®Google Scholar
• García FradeLJde La CalleHAlavaINavarroJLCreightonLJGaffneyPJDiabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damageThromb Res19874755335403118498
   PubMed Web of Science ®Google Scholar
• NomuraSSuzukiMKatsuraKPlatelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitusAtherosclerosis199511622352407575778
   PubMed Web of Science ®Google Scholar
• NomuraSImamuraAOkunoMPlatelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokinesThromb Res200098425726810822072
   PubMed Web of Science ®Google Scholar
• NomuraSOzakiYIkedaYFunction and role of microparticles in various clinical settingsThromb Res2008123182318667228
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuATaomotoKAssessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in JapanJ Atheroscler Thromb200916687888720032575
   PubMed Web of Science ®Google Scholar
• NomuraSShimizuMClinical significance of procoagulant microparticlesJ Intensive Care20153121125705427
   PubMed Web of Science ®Google Scholar
• NomuraSMicroparticle and atherothrombotic diseasesJ Atheroscler Thromb20162311926412494
   PubMed Web of Science ®Google Scholar
• MiyazakiYNomuraSMiyakeTHigh shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticlesBlood1996889345634648896411
   PubMed Web of Science ®Google Scholar
• SinauridzeEIKireevDAPopenkoNYPlatelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated plateletsThromb Haemost200797342543417334510
   PubMed Web of Science ®Google Scholar
• NtaiosGGatselisNKMakaritsisKDalekosGNAdipokines as mediators of endothelial function and atherosclerosisAtherosclerosis2013227221622123332774
   PubMed Web of Science ®Google Scholar
• CarboneFMachFMontecuccoFThe role of adipocytokines in atherogenesis and atheroprogressionCurr Drug Targets201516429532025382206
   PubMed Web of Science ®Google Scholar
• KatsikiNMantzorosCMikhailidisDPAdiponectine, lipids and atherosclerosisCurr Opin Lipidol201728434735428463859
   PubMed Web of Science ®Google Scholar
• MargaritisMAntonopoulosASDigbyJInteractions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vesselsCirculation2013127222209222123625959
   PubMed Web of Science ®Google Scholar
• ChenYJZhangLQWangGPAdiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cellsThromb Haemost2008100229130018690350
   PubMed Web of Science ®Google Scholar
• NomuraSInamiNShouzuAThe effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patientsPlatelets2009201162219172517
   PubMed Web of Science ®Google Scholar
• HayashiTRaniPFukatsuAA new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbitsAtherosclerosis2004176225526315380447
   PubMed Web of Science ®Google Scholar
• NomuraSPitavastatin in the management of hypercholesterolemiaClin Med Ther2009114771488
   Google Scholar
• KobaSSasakiJTreatment of hyperlipidemia from Japanese evidenceJ Atheroscler Thromb200613626728017192691
   PubMed Web of Science ®Google Scholar
• NomuraSKanazawaSFukuharaSEffects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitusJ Diabetes Complications200317315315912738400
   PubMed Web of Science ®Google Scholar
• YokoyamaMOrigasaHMatsuzakiMJapan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blind endopoint analysisLancet200736995671090109817398308
   PubMed Web of Science ®Google Scholar
• ParkSYRheeSYOhSEvaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetesEndocr J201259870971622673600
   PubMed Web of Science ®Google Scholar
• LeeDHChunEJHurJHEffect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetesAtherosclerosis2017257475428068560
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSNishikawaMIwasakaT5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetesBlood Coagul Fibrinolysis200516642342816093733
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSCorrelation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitusThromb Res20081221394517920663
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSEffects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetesJ Atheroscler Thromb2009162839019403992
   PubMed Web of Science ®Google Scholar
• HataYMabuchiHSaitoYInvestigating Committee of Guideline for Diagnosis and Treatment of Hyperlipidemias Japan Atherosclerosis Society. Guideline for Diagnosis and Treatment of Hyperlipidemias in AdultsDoumyakukouka199725134
   Google Scholar
• The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitusDiabetes Care200326Suppl 1S5S2012502614
   PubMed Web of Science ®Google Scholar
• PackhamMAMustardJFThe role of platelets in the development and complications of atherosclerosisSemin Hematol19862318193511536
   PubMed Web of Science ®Google Scholar
• TschoepeDRoesenPEsserJLarge platelets circulate in an activated state in diabetes mellitusSemin Thromb Hemost199117044334381803514
   PubMedGoogle Scholar
• NomuraSTandonNNNakamuraTConeJFukuharaSKambayashiJHigh-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cellsAtherosclerosis2001158227728711583705
   PubMed Web of Science ®Google Scholar
• UchiyamaSDemaerschalkBMGotoSStroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trialsJ Stroke Cerebrovasc Dis200918648249019900653
   PubMed Web of Science ®Google Scholar
• DammanPWoudstraPKuijtWJde WinterRJJamesSKP2Y12 platelet inhibition in clinical practiceJ Thromb Thrombolysis201233214315322183178
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSEffect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetesThromb Haemost19988033883929759615
   PubMed Web of Science ®Google Scholar
• NomuraSInamiNIwasakaTLiuYPlatelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamolePlatelets200415316717215203718
   PubMed Web of Science ®Google Scholar
• HottaKFunahashiTAritaYPlasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patientsArterioscler Thromb Vasc Biol20002061595159910845877
   PubMed Web of Science ®Google Scholar
• YilmazMISonmezACaglarKPeroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuriaEndocrine200425320721415758247
   PubMed Web of Science ®Google Scholar
• NomuraSShouzuAOmotoSNishikawaMFukuharaSIwasakaTEffect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitusThromb Res2006117438539215896827
   PubMed Web of Science ®Google Scholar
• GautamMIzawaAShibaYImportance of fatty acid compositions in patients with peripheral arterial diseasePLoS One201499e10700325191963
   PubMed Web of Science ®Google Scholar
• HishikariKKimuraSYamakamiYThe prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesionsAtherosclerosis2015239258358825733330
   PubMed Web of Science ®Google Scholar
• KumbhaniDJStegPGCannonCPStatin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryEur Heart J201435412864287224585266
   PubMed Web of Science ®Google Scholar